Avecho Biotechnology Ltd (OTCPK:AVEFF)
$ 0.0045 -0.013 (-74.14%) Market Cap: 55.93 Mil Enterprise Value: 52.72 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Avecho Biotechnology Ltd Phase III Interim Analysis Outcome Webinar Transcript

Jun 23, 2026 / 11:30 PM GMT
Release Date Price: $0.0045


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AVE.AX - Avecho Biotechnology Ltd
Avecho Biotechnology Ltd Phase III Interim Analysis Outcome Webinar
Jun 23, 2026 / 11:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thanks for standing by, and welcome to the Aveco Biotechnology Investor Webinar and Q&A this morning, following the announcement of positive interim analysis in its phase three insomnia program. There'll be an initial slide presentation lasting for approximately 20 minutes, followed by Q&A. So if you have a question you'd like to submit, please feel free to type it in using the Q&A function within Zoom, and we'll get to those shortly. On behalf of Aveco today, we again have CEO, Dr. Paul Gavin, and I'll hand it over to him now.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot